Greater insulin resistance in short children born small‐for‐gestational age than in children with growth hormone deficiency at the early period of growth hormone therapy
- 16 January 2021
- journal article
- research article
- Published by Wiley in Pediatrics International
- Vol. 63 (10) , 1180-1184
Abstract
Background: We compared insulin resistance and glucose metabolism during growth hormone (GH) therapy between 43 short children born small‐for‐gestational age (SGA) and 42 children identify as growth hormone deficiency (GHD).Methods: The study compared fasting plasma glucose (FPG), fasting immunoreactive insulin (IRI) and homeostasis model assessment insulin resistance index (HOMA‐IR) during 24‐month GH therapy between the two groups.Results: Mean FPG, fasting IRI, and HOMA‐IR values at 3‐month GH therapy were significantly higher than those before and at 12‐ and 24‐month GH therapy in both groups. These markers were significantly higher in short children born SGA than GHD children until 12‐month GH therapy but were not different at 24‐month GH therapy in both groups.Conclusions: The increased secretion of insulin observed in short children born SGA might be a compensatory mechanism for the prevention of hyperglycemia that can progress to diabetes mellitus. However, these metabolic markers gradually declined after 3 months of GH therapy and returned to baseline values at 24 months. These results suggest that short children born SGA have greater insulin resistance than GHD children at the early period of GH therapy, however, increased insulin resistance is improved over a long period.Keywords
This publication has 29 references indexed in Scilit:
- The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age childrenClinical Endocrinology, 2009
- Fetal Growth Restriction and the Developmental Origins of Adult Disease Hypothesis: Experimental Studies and Biological Consequences2008
- Long‐term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small‐for‐gestational‐age: six‐year follow‐up of a randomized controlled GH trialClinical Endocrinology, 2007
- Food Intake of Children with Short Stature Born Small for Gestational Age before and during a Randomized GH TrialHormone Research in Paediatrics, 2006
- The Risk of Diabetes Mellitus in Children Born Small for Gestational Age and Treated with Recombinant Growth HormoneJournal of Pediatric Endocrinology and Metabolism, 2005
- Dietary restriction in pregnant rats causes gender‐related hypertension and vascular dysfunction in offspringThe Journal of Physiology, 2001
- Body Composition, Blood Pressure, and Lipid Metabolism before and during Long-Term Growth Hormone (GH) Treatment in Children with Short Stature Born Small for Gestational Age Either with or without GH DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 2000
- Growth in utero and serum cholesterol concentrations in adult life.BMJ, 1993
- Fetal and infant growth and impaired glucose tolerance at age 64.BMJ, 1991
- WEIGHT IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASEThe Lancet, 1989